Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Toxicity of aminoglycosides is a major concern in the treatment of continuous ambulatory peritoneal dialysis (CAPD) peritonitis. The relatively high blood levels and prolonged and repeated usage may all be contributory. The recognition of the so-called postantibiotic effect, together with the increased phagocytosis of antibiotic-treated cells, may introduce a new mode of therapy with once-daily dosage. Intermittent therapy with vancomycin is already generally accepted. The extension of this modality to antibiotic therapy is discussed.

Original languageEnglish
Pages (from-to)S355-S356
JournalPeritoneal Dialysis International
Volume13
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Jan 1 1993

Keywords

  • Antibiotics
  • Ototoxicity
  • Peritonitis
  • Treatment

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Single daily dose of aminoglycosides in the treatment of continuous ambulatory peritoneal dialysis peritonitis'. Together they form a unique fingerprint.

  • Cite this